Berberis-homaccord

Berberis-homaccord helps regulate the tone of the bile ducts and urinary organs.

Indications Berberis-homaccord

It is used to eliminate the following problems:

• pathologies and disorders in the functioning of the liver and gastrointestinal tract: colic in the liver, cholecystocholangitis (also its calculous form), dysfunction of the biliary tract, postcholecystectomy syndrome, chronic hepatitis, diarrhea and gastroenterocolitis, as well as pain in the gastrointestinal tract and spastic constipation, intestinal obstruction, bloating and loss of appetite;
• diseases of the urinary system and kidneys: colic in the kidneys, urolithiasis and uric acid diathesis, and in addition cystitis with pyelonephritis and urethritis;
• pathologies in the area of the skin and joints: rheumatic and gouty arthritis and eczema, as well as chronic stress, CFS and severe general exhaustion of the body;
• gynecological disorders: during the postpartum period, with uterine inflammation complicated by bleeding, as well as with atonic uterine bleeding and dysmenorrhea;
• as a drainage agent: for the treatment of various diseases (acute or chronic inflammation, as well as oncological pathologies), detoxification of the body, and restoration of the functioning of autoregulatory systems during a combined disease of various organs. Along with this, it is used to treat toxic reactions and complications during allopathic therapy (chemotherapy and radiation therapy, as well as taking antibiotics);
• autoimmune pathologies of a systemic or inflammatory nature in chronic form, in which long-term treatment with GCS is used.

Release form

Available in drops in 30 ml bottles. Inside a separate pack is 1 bottle with the medicine.

Pharmacodynamics

Medicinal properties of the drug: drainage, analgesic, detoxifying, anti-inflammatory and antispasmodic, as well as choleretic and hepatoprotective. The drug also helps restore the adrenal glands, stabilizes the vegetative balance and mineral metabolism and has an anti-stress and sedative effect.

The combined effect of the antihomotoxic agent is provided by the properties of the elements that make up its composition. These are substances of plant origin:

• Berberis vulgaris – helps stabilize the adrenal glands, as well as the vegetative balance. In addition, it stimulates the drainage activity of the urinary system, gastrointestinal tract, and skin. Reduces the tone of the gallbladder, has an anti-inflammatory effect, improves the processes of bile outflow and relieves pain. Helps remove stones from the urinary tract, and also prevents the appearance of salts. At the same time, it activates the processes of drainage of excess salts inside the tissues;
• Citrullus colocynthis – affects the function of the vasomotor centers, as a result of which the blood circulation process inside the peritoneum organs improves. The substance has a diuretic, detoxifying and antispasmodic effect. Relieves colic in the gastrointestinal tract and hepatobiliary system. It also helps with colic in the liver, while preventing the possibility of their relapse. It is effective in cases of stabbing pain in the joints, as well as in neuralgia with neuritis;
• Veratrumalbum – stabilizes the gastrointestinal tract and its tone, which allows it to be used as an antidiarrheal agent in the treatment of gastroenterocolitis (also of the infectious type, as it has antimicrobial properties). Helps to normalize intestinal function in case of intestinal obstruction. Normalizes the function of the central nervous system during psychosis or stress. The substance is used in the development of neurosis-like conditions or VSD. This component demonstrates maximum effectiveness in case of exhaustion of the body and systemic loss of strength.

Berberis-Homaccord contains an effective complex of medicinal elements with synergistic properties - they affect various areas of the pathogenesis of various diseases of the urinary system and gastrointestinal tract.

The peculiarities of the pharmacological properties of Homaccord (low and high potencies are harmoniously combined in them) provide the medicine with a powerful, persistent and rapid medicinal effect.

Reduces the likelihood of developing a short-term exacerbation to a minimum, and also acts effectively in case of long-term use (a high impact rate is extremely important in eliminating chronic diseases).

In antihomotoxic treatment, the drug is used as one of the main drainage agents. It has multidirectional drainage properties, which allows it to affect 3 excretory organs at once - the skin, the urinary system and the gastrointestinal tract. It also stimulates the adrenal glands (at the stages of neoplasm, the activity of these functions is quite low).

Berberis-Homaccord is safe when used for calculous cholecystocholangitis, because it has a predominantly antispasmodic effect.

Dosing and administration

A single dose requires 10 drops of the medicine. Mix the substance with water (5-15 ml) and then drink it, briefly holding the solution in the mouth. The dose is taken three times a day, before meals (15-20 minutes) or after them (after 1 hour). For the treatment of acute pathologies, a single dose is allowed every 15 minutes, but this can be done for a maximum of 2 hours in a row.

The daily dose can be dissolved in a glass of water and then drunk in small sips throughout the day.

Use Berberis-homaccord during pregnancy

Due to the fact that the substance Berberis vulgaris enhances the processes of uterine contractility, the drug is prohibited during pregnancy.

Contraindications

Among the contraindications:

• hypersensitivity to the components of the drug;
• children under 18 years of age (since there is not enough medicinal information on the use of drugs in this group of patients).

Side effects Berberis-homaccord

The use of drops may cause the occurrence of certain allergic reactions.

[ 1 ]

Storage conditions

The drops should be stored in a dark place protected from moisture penetration. Temperature indicators are within 15-25°C.

Shelf life

Berberis-Homaccord can be used for a period of 5 years from the date of release of medicinal drops.